Your browser doesn't support javascript.
loading
GFI1 as a novel prognostic and therapeutic factor for AML/MDS.
Hönes, J M; Botezatu, L; Helness, A; Vadnais, C; Vassen, L; Robert, F; Hergenhan, S M; Thivakaran, A; Schütte, J; Al-Matary, Y S; Lams, R F; Fraszscak, J; Makishima, H; Radivoyevitch, T; Przychodzen, B; da Conceição Castro, S V; Görgens, A; Giebel, B; Klein-Hitpass, L; Lennartz, K; Heuser, M; Thiede, C; Ehninger, G; Dührsen, U; Maciejewski, J P; Möröy, T; Khandanpour, C.
Afiliación
  • Hönes JM; Department of Hematology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
  • Botezatu L; Department of Hematology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
  • Helness A; Institut de recherches cliniques de Montréal (IRCM), Hematopoiesis and Cancer Research Unit, and Mc Gill University, Montréal, Canada.
  • Vadnais C; Institut de recherches cliniques de Montréal (IRCM), Hematopoiesis and Cancer Research Unit, and Université de Montréal, Montréal, Canada.
  • Vassen L; Department of Hematology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
  • Robert F; Institut de recherches cliniques de Montréal (IRCM), Chromatin and Genomic Expression Research Unit, and Université de Montréal, Montréal, Canada.
  • Hergenhan SM; Department of Hematology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
  • Thivakaran A; Department of Hematology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
  • Schütte J; Department of Hematology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
  • Al-Matary YS; Department of Hematology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
  • Lams RF; Department of Hematology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
  • Fraszscak J; Institut de recherches cliniques de Montréal (IRCM), Hematopoiesis and Cancer Research Unit, and Université de Montréal, Montréal, Canada.
  • Makishima H; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, USA.
  • Radivoyevitch T; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, USA.
  • Przychodzen B; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, USA.
  • da Conceição Castro SV; Institute for Transfusion Medicine, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
  • Görgens A; CAPES Foundation, Ministry of Education of Brazil, Brasília, Brazil.
  • Giebel B; Institute for Transfusion Medicine, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
  • Klein-Hitpass L; Institute for Transfusion Medicine, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
  • Lennartz K; Institute for Cell Biology (Tumor Research), University Hospital Essen, University Duisburg-Essen, Germany.
  • Heuser M; Institute for Cell Biology (Tumor Research), University Hospital Essen, University Duisburg-Essen, Germany.
  • Thiede C; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Ehninger G; Medical Clinic and Polyclinic, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.
  • Dührsen U; Medical Clinic and Polyclinic, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.
  • Maciejewski JP; Department of Hematology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
  • Möröy T; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, USA.
  • Khandanpour C; Institut de recherches cliniques de Montréal (IRCM), Hematopoiesis and Cancer Research Unit, and Université de Montréal, Montréal, Canada.
Leukemia ; 30(6): 1237-45, 2016 06.
Article en En | MEDLINE | ID: mdl-26847026
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Factores de Transcripción / Síndromes Mielodisplásicos / Leucemia Mieloide Aguda / Epigénesis Genética / Proteínas de Unión al ADN Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2016 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Factores de Transcripción / Síndromes Mielodisplásicos / Leucemia Mieloide Aguda / Epigénesis Genética / Proteínas de Unión al ADN Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2016 Tipo del documento: Article País de afiliación: Alemania